EP3401335 - COMPOSITION COMPRISING ANTIBODY THAT BINDS TO DOMAIN II OF HER2 AND ACIDIC VARIANTS THEREOF [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 28.05.2021 Database last updated on 19.10.2024 | |
Former | Grant of patent is intended Status updated on 18.05.2021 | ||
Former | Examination is in progress Status updated on 20.11.2020 | ||
Former | Request for examination was made Status updated on 17.05.2019 | ||
Former | The application has been published Status updated on 12.10.2018 | Most recent event Tooltip | 29.05.2024 | New entry: Date of oral proceedings | Applicant(s) | For all designated states Genentech, Inc. 1 DNA Way South San Francisco, CA 94080 / US | [2018/46] | Inventor(s) | 01 /
HARRIS, Reed J. 1587 Forge Road San Mateo, CA 94402 / US | 02 /
MOTCHNIK, Paul A. 1020 Lassen Drive Belmont, CA 94002 / US | [2018/46] | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [2021/26] |
Former [2018/46] | Walton, Seán Malcolm, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | Application number, filing date | 18157419.5 | 28.01.2009 | [2018/46] | Priority number, date | US20080024825P | 30.01.2008 Original published format: US 24825 P | [2018/46] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3401335 | Date: | 14.11.2018 | Language: | EN | [2018/46] | Type: | B1 Patent specification | No.: | EP3401335 | Date: | 30.06.2021 | Language: | EN | [2021/26] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 01.10.2018 | Classification | IPC: | C07K16/32, C07K16/06, C07K1/18, // A61K39/395, A61P35/00 | [2018/46] | CPC: |
C07K16/32 (EP,US);
A61P1/04 (EP);
A61P11/00 (EP);
A61P15/00 (EP);
A61P35/00 (EP);
C07K1/18 (US);
C07K16/065 (EP,US);
C07K16/2863 (EP,US);
C07K16/2896 (EP,US);
A61K2039/505 (US);
C07K2317/24 (US);
C07K2317/41 (EP,US);
C07K2317/76 (US);
G01N2030/027 (US);
G01N27/447 (US);
G01N30/02 (US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2019/25] |
Former [2018/46] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR | Extension states | AL | 10.05.2019 | BA | 10.05.2019 | RS | 10.05.2019 | Title | German: | ZUSAMMENSETZUNG MIT EINEM AN HER2-DOMÄNE II BINDENDEN ANTIKÖRPER UND SAURE VARIANTEN DAVON | [2018/46] | English: | COMPOSITION COMPRISING ANTIBODY THAT BINDS TO DOMAIN II OF HER2 AND ACIDIC VARIANTS THEREOF | [2018/46] | French: | COMPOSITION COMPRENANT UN ANTICORPS SE LIANT AU DOMAINE II DE HER2 ET VARIANTES ACIDES DE CELLE-CI | [2018/46] | Biological material | This application mentions deposited biological material, check the file for details | Examination procedure | 10.05.2019 | Examination requested [2019/25] | 10.05.2019 | Date on which the examining division has become responsible | 21.06.2019 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | 29.08.2019 | Amendment by applicant (claims and/or description) | 19.11.2020 | Despatch of a communication from the examining division (Time limit: M04) | 24.11.2020 | Reply to a communication from the examining division | 19.05.2021 | Communication of intention to grant the patent | 20.05.2021 | Fee for grant paid | 20.05.2021 | Fee for publishing/printing paid | 20.05.2021 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP09709065.8 / EP2238172 | Divisional application(s) | EP21181102.1 / EP4119583 | Opposition(s) | Opponent(s) | 01
08.11.2021
31.03.2022
ADMISSIBLE Hexal AG Industriestrasse 25 83607 Holzkirchen / DE Opponent's representative König Szynka Tilmann von Renesse Patentanwälte Partnerschaft mbB Düsseldorf, et al, et al Mönchenwerther Straße 11 40545 Düsseldorf / DE | 02
22.03.2022
24.03.2022
ADMISSIBLE Pohlman, Sandra M. Fünf Höfe Theatinerstraße 16 80333 München / DE Opponent's representative Pohlman, Sandra M. df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Theatinerstrasse 16 80333 München / DE | 03
28.03.2022
30.03.2022
ADMISSIBLE Strawman Limited Orchard Lea Horns Lane Combe, Witney Oxfordshire OX29 8NH / GB Opponent's representative Gill Jennings & Every LLP The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB | 04
30.03.2022
04.04.2022
ADMISSIBLE Abel & Imray LLP 20 St. Andrew Street London EC4A 3AG / GB Opponent's representative Abel & Imray LLP Westpoint Building James Street West Bath BA1 2DA / GB | 05
30.03.2022
04.04.2022
ADMISSIBLE European Oppositions Limited Lacon London 84 Theobalds Road London WC1X 8NL / GB Opponent's representative Kilburn & Strode LLP, et al, et al Lacon London 84 Theobalds Road Holborn London WC1X 8NL / GB | [N/P] |
Former [2022/30] | |||
Opponent(s) | 01
08.11.2021
31.03.2022
ADMISSIBLE Hexal AG Industriestrasse 25 83607 Holzkirchen / DE Opponent's representative König Szynka Tilmann von Renesse Patentanwälte Partnerschaft mbB Düsseldorf, et al, et al Mönchenwerter Straße 11 40545 Düsseldorf / DE | ||
02
22.03.2022
24.03.2022
ADMISSIBLE Pohlman, Sandra M. Fünf Höfe Theatinerstraße 16 80333 München / DE Opponent's representative Pohlman, Sandra M. df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Theatinerstrasse 16 80333 München / DE | |||
03
28.03.2022
30.03.2022
ADMISSIBLE Strawman Limited Orchard Lea Horns Lane Combe, Witney Oxfordshire OX29 8NH / GB Opponent's representative Gill Jennings & Every LLP The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB | |||
04
30.03.2022
04.04.2022
ADMISSIBLE Abel & Imray LLP 20 St. Andrew Street London EC4A 3AG / GB Opponent's representative Abel & Imray LLP Westpoint Building James Street West Bath BA1 2DA / GB | |||
05
30.03.2022
04.04.2022
ADMISSIBLE European Oppositions Limited Lacon London 84 Theobalds Road London WC1X 8NL / GB Opponent's representative Kilburn & Strode LLP, et al, et al Lacon London 84 Theobalds Road Holborn London WC1X 8NL / GB | |||
Former [2022/18] | |||
Opponent(s) | 01
08.11.2021
31.03.2022
ADMISSIBLE Hexal AG Industriestrasse 25 83607 Holzkirchen / DE Opponent's representative Roth, Carla, et al, et al König-Szynka-Tilmann-von Renesse Patentanwälte Partnerschaft mbB Mönchenwerther Straße 11 40545 Düsseldorf / DE | ||
02
22.03.2022
24.03.2022
ADMISSIBLE Pohlman, Sandra M. Fünf Höfe Theatinerstraße 16 80333 München / DE Opponent's representative Pohlman, Sandra M. df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Theatinerstrasse 16 80333 München / DE | |||
03
28.03.2022
30.03.2022
ADMISSIBLE Strawman Limited Orchard Lea Horns Lane Combe, Witney Oxfordshire OX29 8NH / GB Opponent's representative Gill Jennings & Every LLP The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB | |||
04
30.03.2022
Abel & Imray LLP 20 St. Andrew Street London EC4A 3AG / GB Opponent's representative Abel & Imray LLP Westpoint Building James Street West Bath BA1 2DA / GB | |||
05
30.03.2022
European Oppositions Limited Lacon London 84 Theobalds Road London WC1X 8NL / GB Opponent's representative Kilburn & Strode LLP, et al, et al Lacon London 84 Theobalds Road Holborn London WC1X 8NL / GB | |||
Former [2022/17] | |||
Opponent(s) | 01
08.11.2021
Hexal AG Industriestrasse 25 83607 Holzkirchen / DE Opponent's representative Roth, Carla, et al, et al König-Szynka-Tilmann-von Renesse Patentanwälte Partnerschaft mbB Mönchenwerther Straße 11 40545 Düsseldorf / DE | ||
02
22.03.2022
24.03.2022
ADMISSIBLE Pohlman, Sandra M. Fünf Höfe Theatinerstraße 16 80333 München / DE Opponent's representative Pohlman, Sandra M. df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Theatinerstrasse 16 80333 München / DE | |||
Former [2021/50] | |||
Opponent(s) | 01
08.11.2021
Hexal AG Industriestrasse 25 83607 Holzkirchen / DE Opponent's representative Roth, Carla, et al, et al König-Szynka-Tilmann-von Renesse Patentanwälte Partnerschaft mbB Mönchenwerther Straße 11 40545 Düsseldorf / DE | 28.03.2022 | No. 01: Notification indicating deficiencies in the notice of opposition | 30.03.2022 | No. 01: Reply to notification indicating deficiencies in the notice of opposition | 11.04.2022 | Invitation to proprietor to file observations on the notice of opposition | 21.10.2022 | Reply of patent proprietor to notice(s) of opposition | 06.03.2023 | Despatch of a communication from the opposition division (Time limit: M06) | 18.09.2023 | Reply to a communication from the opposition division | 24.03.2025 | Date of oral proceedings | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 29.08.2019 | Request for further processing filed | 29.08.2019 | Full payment received (date of receipt of payment) Request granted | 13.09.2019 | Decision despatched | Fees paid | Renewal fee | 05.03.2018 | Renewal fee patent year 03 | 05.03.2018 | Renewal fee patent year 04 | 05.03.2018 | Renewal fee patent year 05 | 05.03.2018 | Renewal fee patent year 06 | 05.03.2018 | Renewal fee patent year 07 | 05.03.2018 | Renewal fee patent year 08 | 05.03.2018 | Renewal fee patent year 09 | 05.03.2018 | Renewal fee patent year 10 | 09.01.2019 | Renewal fee patent year 11 | 10.01.2020 | Renewal fee patent year 12 | 12.01.2021 | Renewal fee patent year 13 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]EP1308455 (GENENTECH INC [US]); | [X]WO2006033700 (GENENTECH INC [US], et al); | by applicant | US3773919 | EP0003089 | US4485045 | US4544545 | US4676980 | US4816567 | US4933294 | US4943533 | US4968603 | EP0404097 | WO9100360 | WO9105264 | US5013556 | WO9220373 | US5183884 | US5208020 | WO9308829 | US5212290 | WO9311161 | US5229275 | WO9316185 | WO9321319 | WO9321232 | US5264586 | WO9400136 | WO9404690 | WO9411026 | EP0599274 | WO9422478 | US5401638 | EP0659439 | US5457105 | US5475001 | US5480968 | WO9603397 | US5500362 | WO9616673 | US5545807 | WO9630347 | US5565332 | US5567610 | WO9633978 | WO9633980 | US5571894 | US5573905 | WO9640210 | US5587458 | US5589369 | WO9700271 | US5591669 | WO9704801 | US5616582 | US5641869 | US5641870 | US5654307 | WO9730087 | US5677171 | US5679683 | WO9738983 | WO9738731 | WO9802463 | US5712374 | US5714586 | US5731168 | WO9814451 | US5739277 | WO9817797 | US5747498 | US5760041 | US5766863 | US5770599 | US5772997 | US5773001 | US5783186 | US5804396 | WO9843960 | US5821337 | WO9845479 | US5824311 | WO9850433 | WO9850038 | US5837234 | WO9858964 | US5866572 | WO9906378 | WO9906396 | WO9909016 | US5891996 | WO9919488 | WO9922764 | WO9924037 | WO9951642 | US6002008 | US6084095 | WO0042072 | US6140332 | WO0100245 | US6194551 | US6235883 | US6242195 | US6265410 | US2002004587 | US6339142 | US6344459 | US6344455 | US6391874 | US6399602 | US6455534 | WO03011878 | US6521620 | US6528624 | US6538124 | US6596726 | US6602863 | US6602684 | US2003157108 | WO03086467 | US6713484 | US2004093621 | US2005101617 | US6949245 | US2006013819 | US2006018899 | US2006088523 | US2007020261 | Opposition | WO2006033700 | WO2006044908 | WO2006063042 | WO2006078307 | WO2006091693 | WO2006096861 | WO2007013950 | WO2007145862 | WO2014172371 | WO9957134 | WO0100245 | WO2004008099 | WO2009099829 |